NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) to Present at Seventh Annual ARM Cell & Gene Therapy Investor Day in New York City

Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) this morning announced that it will be presenting at the upcoming ARM Cell & Gene Therapy Investor Day, hosted by the Alliance for Regenerative Medicine, to be held in New York City on March 21, 2019. Unique to the medical and biotech communities, the investor conference focuses on fast-paced, concise presentations from more than 35 companies, consolidated to a one-day conference while allowing opportunities for one-on-one partnering with venture and strategic investors. Genprex’s presentation is scheduled for Thursday, March 21, at 2:30-2:45 p.m. EDT in the Main Bar Room of the Metropolitan Club, One East 60th Street, New York, NY 10022. “I’m looking forward to attending Cell & Gene Therapy Investor Day for the first time, with the opportunity to share information about Genprex’s mission and our gene therapy technologies,” Genprex President and COO Julien Pham, MD, MPH said in the news release. “With a wide array of companies and industry leaders all presenting in a single day, this conference enables us and the investment community to take the pulse of where the industry is heading. It is an incredible honor to be a part of this event.”

To view the full press release, visit http://nnw.fm/bHQ7E

About Genprex, Inc.

Genprex, Inc. is a clinical stage gene therapy company developing potentially life-changing technologies for cancer patients, based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex(TM) immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. Oncoprex has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis, or programmed cell death, in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. For more information, visit the company’s website at www.Genprex.com.

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Latest News

Arkansas newspaper gambles on free iPads as the future

May 26, 2019

HOPE, Ark. — Over a lunch of hamburger steaks, mashed potatoes and green beans, Walter Hussman delivered his pitch to the dozen or so attendees of the Hope, Arkansas, Rotary Club meeting. He promised that if they keep paying their current rate of $36 a month for subscription to the Arkansas Democrat-Gazette newspaper, even though it will no longer be printed daily or delivered to their door, they'll get a free iPad to view a digital version. The daily digital replica of the state's largest newspaper will be accessed with an easy-to-use app they can download on the tablet that...

AP FACT CHECK: Trump and a tale of 2 sheets of paper

May 26, 2019

WASHINGTON — President Donald Trump held up and read from a sheet of paper in the Rose Garden this past week as he argued he's been hounded by investigators in the Russia probe for no reason. "Nearly 500 search warrants," says the page, from an ABC News graphic. "More than 2,500 subpoenas." And: "19 special counsel lawyers & 40 FBI agents worked the case." If that sounds like overkill by the Robert Mueller inquiry, it's only half the story. Trump did not show or quote from a second page that goes with the graphic, laying out the results of the...

The Latest: Trump, in Japan, needles US ally over trade

May 26, 2019

TOKYO — The Latest on President Donald Trump's state visit to Japan. (all times local): 12:30 a.m. Sunday President Donald Trump has begun a state visit to Japan by needling the American ally over its trade imbalance with the United States. He jokingly tells business leaders at a reception in Tokyo: "Maybe that's why you like me so much." Trump also is promoting the U.S. under his leadership. He says "there's never been a better time" to invest or do business in America, and he urges corporate leaders to come. ___ 7 p.m. What stands nearly 5 feet (1.5 meters)...

Trump opens state visit, needles Japan over trade issues

May 26, 2019

TOKYO — President Donald Trump opened a state visit to Japan on Saturday by needling the country over its trade imbalance with the United States. "Maybe that's why you like me so much," he joshed. Trump also promoted the U.S. under his leadership, saying "there's never been a better time" to invest or do business in America, and he urged corporate leaders to come. The president's first event after arriving in Tokyo was a reception with several dozen Japanese and American business leaders at the U.S. ambassador's residence. He said the two countries "are hard at work" negotiating a trade...

The Latest: PM May resigns, won't lead Britain out of EU

May 26, 2019

LONDON — The Latest on Brexit and Britain's political crisis (all times local): 8:15 p.m. Theresa May has ended her failed three-year quest to lead Britain out of the European Union, announcing that she will step down as Conservative Party leader June 7 and triggering a contest to choose a new prime minister who will try to complete Brexit. May says Friday in a speech outside 10 Downing St. in London, that "I have done my best" before acknowledging that it was not good enough. She struggled to contain her emotions and her voice broke as she expressed "enduring gratitude...

Search

Deck Biz is an intelligent platform providing international and regional business news updates. You won’t get these insights elsewhere other than Deck Biz.

Contact us: sales@deckbiz.com